摘要
IntravesicalBacillusCalmette-Guérin(BCG)haslongbeenthegoldstandardtreatmentofnonmuscleinvasivebladdercancer.Recently,therehasbeenanemergenceofnovelimmunotherapeuticagents,whichhaveshownpromiseinthetreatmentofurothelialcellcarcinoma.Theseagentsaimtoaugment,modify,orenhancetheimmuneresponse.SuchstrategiesincluderecombinantBCG,monoclonalantibodies,vaccines,genetherapy,andadoptiveT-celltherapy.Here,wereviewtheemergingimmunotherapeuticsinthetreatmentofnonmuscleinvasivebladdercancer.
出版日期
2016年02月12日(中国Betway体育网页登陆平台首次上网日期,不代表论文的发表时间)